INNOVATION FOR SPECIALISTS, created in 2005 (Belgium), from 359 sister brands and 2214 competing brands. The INNOVATION FOR SPECIALISTS brand is owned by UCB, a company listed in Bruxelles. The ISIN, the company's International Securities Identification Number, is BE0003739530. INNOVATION FOR SPECIALISTS belongs to the Biotechnology business sector.
Buy UCB share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Other brands
UCB
-
A
-
B
-
C
- CimpleCare
- CimpleTrack
- CIM-Pal
- Cardiket
- CLUZELA
- CUPEDAN
- CDS
- CARDIOTENSIN
- CELLTECH
- cimzia
- CHIROCAINE
- CHIROSCIENCE
- C-EARLY
- CIMple Clicks
- Crohn's & me
- CROZIA
- COVAL
- CONFIDAN
- CETI
- CTZ
- CTZ-UCB
- CRONEPARINA
- CARDIPLAST
- CANDOX
- CLAROBRAINE
- CORTIBRAINE
- CARTRAX
- CORDERAX
- COLIPAR
- CONDROTIN
- cordisanol
- CHOLEPAR
- CELLODIN
- CHARDYL
-
D
-
E
- EPI-MANAGER
- EPI-INTERACT
- ENFROSA
- ELZERIO
- EXENTRO
- ELANTAN
- EPAAC TM The new generation of ETAC TM Early Prevention of Asthma in Atopic Children
- Evenity
- EZELBA
- EQULAN
- EMUZIQ
- epilepsy 2.0
- EMULATE
- EMBODY
- EMBLEM
- EVETROL
- EPILOX
- EPRIDE
- EASY-DUO
- EDEX DUOPEN
- EDEX DUO
- EDEX DUOJECT
- ETAC
- ESSENTIALIA
- ENDOBRAINE
- ESUFLO
- ENARAX
- ENTEFUGE
- ergo sanol
- EPARSION
-
F
-
G
-
H
-
I
-
K
-
L
-
M
-
N
-
O
-
P
-
Q
-
R
-
S
- STELOX
- SOPRAS
- SINTOBÉN
- SOMATOSTATIN-UCB
- SENTOBÉN
- SENBARI
- SYNVOXA
- SYVONA
- sigma
- SELEPTRIS
- SCHWARZ PHARMA
- SITOR
- sKate Strenghts of Keppra as Adjunctive Therapy in Epilepsy
- SKATE SAFETY OF KEPPRA AS ADJUNCTIVE THERAPY IN EPILEPSY
- SEGLOR RETARD
- SPASMO-GENTAROL
- SIDAPHANE
- STIMUCORTEX
- STIMUBRAINE
- STATIBRAINE
- SIDASEAL
- STABANIM
- SOCIETE RECIPE
- SPARTOCINE
- SEDOTUSSIN
- SULFAMYCINE
- SPASMEXINE
- SEDAGRIP
- SIDAC
- SIDATHENE
- SULFATRIX
-
T
-
U
- UCB INTEGRITY LINE
- ucb Inspired by patients. Driven by science.
- UCB Best for Patient
- UCBEST FOR PATIENT
- ucb CNS Innovation Inspired by patients.
- ucb newmedicines vital science new ways
- UCB THE EPILEPSY COMPANY
- ucb OSCAR Observational Study in Children with Allergies and Recurrent symptoms
- UCBeyond
- UCB INNOVATION FOR SPECIALISTS
- UCESTATINE
- UCESOL
- URVAN
- UCEPHA
- UCEMINE
- UCB UNION CHIMIQUE BELGE
- UCEMYCINE
- UCEPAM
- UNION CHIMIQUE BELGE
- UCEPARINE
- UCEQUINE
-
V
-
W
-
X
-
Z
